Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Sweden Two bills aiming to classify cannabinoids as narcotics notified to TRIS ...
  • Poland Online prescriptions of medical cannabis now prohibited ...
  • Germany Coalition collapse could affect Pillar 2 of cannabis framework ...
  • South Dakota - United States Voters reject legalising recreational cannabis for a third time ...
  • Nebraska - United States Two medical cannabis-related initiatives gain support from voters ...
  • North Dakota - United States Measure legalising recreational cannabis fails for a third time ...
  • Florida - United States Initiative to legalise recreational cannabis fails to get necessary support ...
  • Switzerland Synthetic cannabinoids are added to narcotics list ...
  • Ukraine Government regulates procedure for the circulation of medical cannabis ...
  • Florida - Nebraska - North Dakota - South Dakota - United States Voting on cannabis legalisation takes place in several states today ...
  • Germany Cannabis club makes first distribution to members ...
  • Ukraine Medical cannabis yet to be cultivated or imported ...
View all
News analysis

Brazil becomes top market for Colombia’s cannabis exports amid regulatory shifts

Written by || 13th September 2024 || News analysis | Cannabis – medical | Import/export | Regulation and legislation | GeographiesAustralasia Australia Brazil Colombia Europe Germany South America United Kingdom

In 2023, Brazil became the largest market for Colombia’s thriving cannabis industry, representing 32% of Colombia’s total cannabis exports – around $3.4m. Data from ProColombia and Colombia’s National Administrative Department of Statistics (DANE) highlights the growing trade between the two nations, driven by regulatory shifts and Colombia’s determination to dominate the international cannabis market.

This surge in exports is the result of strategic political and economic moves in both Brazil and Colombia. Since its inception in 2017 under decree 613, Colombia’s medical cannabis industry has focused heavily on exports due to regulatory gaps that limited domestic growth.

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.